Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

1.70
+0.03001.80%
Post-market: 1.750.0500+2.94%19:59 EST
Volume:1.57M
Turnover:2.70M
Market Cap:304.30M
PE:-5.44
High:1.78
Open:1.67
Low:1.65
Close:1.67
52wk High:2.71
52wk Low:0.3418
Shares:179.00M
Float Shares:112.00M
Volume Ratio:1.29
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3127
EPS(LYR):-1.6093
ROE:-14.24%
ROA:-4.47%
PB:1.73
PE(LYR):-1.06

Loading ...

Century Therapeutics files to sell 176.09M shares of common stock for holders

TIPRANKS
·
Yesterday

Century Therapeutics Files Prospectus to Offer, Resale From Time to Time by Selling Stockholders of up to 176.1 Mln Shares of Common Stock

THOMSON REUTERS
·
Yesterday

Century Therapeutics Inc held special shareholder meeting

Reuters
·
Jan 26

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

TIPRANKS
·
Jan 24

Century Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Jan 20

Century Therapeutics price target raised to $4 from $2 at Piper Sandler

TIPRANKS
·
Jan 20

Top Midday Gainers

MT Newswires Live
·
Jan 09

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

TIPRANKS
·
Jan 09

Century Therapeutics Shares Hit 52-Week High After Private Placement Deal

Dow Jones
·
Jan 08

BRIEF-Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813

Reuters
·
Jan 08

Century Therapeutics Inc - Financing Led by Tcgx With Multiple Investors Participating

THOMSON REUTERS
·
Jan 08

Press Release: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes

Dow Jones
·
Jan 08

Chief Scientific Officer Chad Cowan Reports Acquisition of Century Therapeutics Inc Common Shares

Reuters
·
Dec 30, 2025

Century Therapeutics Director Carlo Rizzuto Resigns

Reuters
·
Dec 30, 2025

3 Promising Penny Stocks With Market Caps Over $30M

Simply Wall St.
·
Dec 19, 2025

Century Therapeutics CEO Brent Pfeiffenberger Reports Acquisition of Common Shares

Reuters
·
Dec 17, 2025

Century Therapeutics Inc Files Initial Statement of Beneficial Ownership for Director Han Myung Lee

Reuters
·
Dec 12, 2025

Century Therapeutics Appoints Han Lee and Martin Murphy to Board

Reuters
·
Dec 09, 2025

Press Release: Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors

Dow Jones
·
Dec 09, 2025

We're Keeping An Eye On Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate

Simply Wall St.
·
Nov 30, 2025